Electrochemical study of the antiplatelet agent clopidogrel and its determination using differential pulse voltammetry in bulk form and pharmaceutical preparations with a glassy carbon electrode.
In the present study, the electroanalytical behaviour of clopidogrel (CLP) bisulfate, an antithrombotic drug, was investigated by cyclic voltammetry (CV) and differential pulse voltammetry (DPV) techniques using a glassy carbon electrode (GCE). The anodic oxidation of clopidogrel bisulfate was investigated with a GCE to determine the oxidation conditions. The voltammograms of solutions having various concentrations of clopidogrel were recorded in order to obtain the optimum oxidation conditions of this drug on a GCE. To determine the effects of the nature of the supporting electrolyte, pH and scan rate on the anodic oxidation reactions, the experiments were performed in 0.2 M sulphuric acid, and in Britton-Robinson (BR) (pH 2-5) and acetate (pH 3.5-5.63) buffers with a 10-400 mVs(-1) scan rate interval. The oxidation of clopidogrel bisulfate was found to be diffusion-controlled over a concentration range of 0.08 mM-1.0 mM in pH 3.7 acetate buffer by an optimized DPV technique. The voltammetric method developed was applied to the tablet form of pharmaceutical preparation of this compound and the accuracy, precision, selectivity, sensitivity, repeatibility within and between days and reproducibility of the proposed method was investigated statistically. The results were compared with the spectrophotometric and HPLC methods developed in our laboratory and found to be in good agreement. No interference was observed from common pharmaceutical adjuvants.
Dermiş
S
S
Ankara University, Faculty of Pharmacy, Department of Analytical Chemistry, Tandoğan-Ankara, Turkey. dermis@pharmacy.ankara.edu.tr
Aydoğan
E
E
D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D000077144:Clopidogrel; D004304:Dosage Forms; D004563:Electrochemistry; D004566:Electrodes; D006863:Hydrogen-Ion Concentration; D007202:Indicators and Reagents; D019999:Pharmaceutical Solutions; D010975:Platelet Aggregation Inhibitors / Q000032:analysis / Q000737:chemistry*; D013056:Spectrophotometry, Ultraviolet; D013607:Tablets; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000032:analysis / Q000737:chemistry
D004304:Dosage Forms; D007202:Indicators and Reagents; D019999:Pharmaceutical Solutions; D010975:Platelet Aggregation Inhibitors; D013607:Tablets; D000077144:Clopidogrel; D013988:Ticlopidine